Endotoxin and cytokine release in strangulation obstruction and in partial occlusion of the mesenteric artery in pigs

被引:8
作者
Fevang, J [1 ]
Ovrebo, K [1 ]
Svanes, K [1 ]
Rokke, O [1 ]
机构
[1] Univ Bergen, Haukeland Hosp, Dept Surg, Inst Surg, N-5021 Bergen, Norway
关键词
strangulation obstruction; endotoxin; cytokines; interleukin-1; interleukin-6; tumor necrosis factor;
D O I
10.1159/000008618
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The study was performed to determine if endotoxin or the cytokines interleukin-1 (IL-1), interleukin-6 (IL-6) and tumor necrosis factor (TNF) are liberated from strangulated or partially ischemic small bowel. Methods: Strangulation obstruction was induced by elevating pressure in a gasket placed around a loop of ileum until venous pressure reached 50 mm Hg. Low arterial flow in a loop of ileum was produced by arterial clamping reducing blood flow by 70%. A proximal bower loop was used for control. Arterial blood flow was measured by transit time flowmetry. Blood samples were collected before and after 30, 90 and 180 min of strangulation or clamping. Plasma levels of endotoxin and cytokines (TNF, IL-l and IL-6) were measured by limulus amebocyte lysate test and bioassays, respectively. Results: Strangulation obstruction caused more extensive mucosal damage than arterial clamping. Strangulation was followed by markedly increased venous concentration and release of IL-6 in the strangulated loop. Partial arterial occlusion did not cause increased release of IL-6. Strangulation or partial clamping did not influence the concentration of endotoxin, IL-1 or TNF in intestinal venous blood. Conclusions: Strangulation obstruction causes increased release of IL-6 to intestinal venous blood. IL-6 levels did not increase after 70% reduction of arterial blood flow. The early IL-6 increase was not detected in systemic blood. Strangulation did not cause early changes in plasma levels of endotoxin, TNF or IL-1.
引用
收藏
页码:26 / 38
页数:13
相关论文
共 36 条
[1]   PRODUCTION OF HYBRIDOMA GROWTH-FACTOR BY HUMAN-MONOCYTES [J].
AARDEN, LA ;
DEGROOT, ER ;
SCHAAP, OL ;
LANSDORP, PM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1987, 17 (10) :1411-1416
[2]   HYPOXIA REOXYGENATION STIMULATES ENDOTHELIAL-CELLS TO PROMOTE INTERLEUKIN-1 AND INTERLEUKIN-6 PRODUCTION - EFFECTS OF FREE-RADICAL SCAVENGERS [J].
ALA, Y ;
PALLUY, O ;
FAVERO, J ;
BONNE, C ;
MODAT, G ;
DORNAND, J .
AGENTS AND ACTIONS, 1992, 37 (1-2) :134-139
[3]   Interleukin-6 in the injured patient marker of injury or mediator of inflammation? [J].
Biffl, WL ;
Moore, EE ;
Moore, FA ;
Peterson, VM .
ANNALS OF SURGERY, 1996, 224 (05) :647-664
[4]  
BISHOP RF, 1960, BRIT MED J, V12, P766
[5]  
CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478
[6]  
CICCO NA, 1990, BLOOD, V75, P2049
[7]   RESPONSE OF SERUM INTERLEUKIN-6 IN PATIENTS UNDERGOING ELECTIVE SURGERY OF VARYING SEVERITY [J].
CRUICKSHANK, AM ;
FRASER, WD ;
BURNS, HJG ;
VANDAMME, J ;
SHENKIN, A .
CLINICAL SCIENCE, 1990, 79 (02) :161-165
[8]  
DEITCH EA, 1989, ARCH SURG-CHICAGO, V124, P699
[9]   A HIGHLY SENSITIVE CELL-LINE, WEHI-164 CLONE 13, FOR MEASURING CYTOTOXIC FACTOR TUMOR-NECROSIS-FACTOR FROM HUMAN-MONOCYTES [J].
ESPEVIK, T ;
NISSENMEYER, J .
JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 95 (01) :99-105
[10]  
FRIBERGER A, 1982, ANONYMOUS ENDOTOXINS, P195